- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
迄今为止，共2家主力机构，持仓量总计41.10万股，占流通A股1.37%
- 波段诊断：
-
技术面诊股
诊断结果：5.6技术面打败了50%的股票
技术面评分前10的股票
近期的平均成本为90.06元，股价在成本上方运行。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为90.06元，股价在成本上方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"90.06","date":1623916950,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2021.06.18","stock":"2.66","trade":"1.60","ind":"0.77"},{"date":"2021.06.17","stock":"1.68","trade":"0.63","ind":"1.23"},{"date":"2021.06.16","stock":"-1.26","trade":"-1.73","ind":"-2.57"},{"date":"2021.06.15","stock":"-1.09","trade":"-1.10","ind":"-0.86"},{"date":"2021.06.11","stock":"-1.75","trade":"-1.54","ind":"-0.62"},{"date":"2021.06.10","stock":"0.39","trade":"-0.18","ind":"1.19"},{"date":"2021.06.09","stock":"-0.33","trade":"-0.07","ind":"0.01"},{"date":"2021.06.08","stock":"-3.10","trade":"-1.47","ind":"-0.98"},{"date":"2021.06.07","stock":"-0.86","trade":"0.48","ind":"-0.06"},{"date":"2021.06.04","stock":"1.70","trade":"0.57","ind":"0.74"},{"date":"2021.06.03","stock":"-2.06","trade":"-1.24","ind":"-0.65"},{"date":"2021.06.02","stock":"-4.87","trade":"-3.13","ind":"-1.18"},{"date":"2021.06.01","stock":"-0.75","trade":"1.10","ind":"0.26"},{"date":"2021.05.31","stock":"5.51","trade":"3.97","ind":"0.97"},{"date":"2021.05.28","stock":"-2.19","trade":"-1.27","ind":"-0.30"},{"date":"2021.05.27","stock":"8.02","trade":"1.39","ind":"0.70"},{"date":"2021.05.26","stock":"0.12","trade":"0.02","ind":"-0.36"},{"date":"2021.05.25","stock":"1.69","trade":"2.19","ind":"2.34"},{"date":"2021.05.24","stock":"0.48","trade":"-0.02","ind":"0.62"},{"date":"2021.05.21","stock":"-3.15","trade":"-0.82","ind":"-0.81"},{"date":"2021.05.20","stock":"0.44","trade":"0.59","ind":"0.35"}]
明德生物,深证成指,医疗器械服务指数
压力支撑
该股压力位为89.43元，支撑位为87.56元。
[{"text":"\u538b\u529b\u4f4d","value":"89.43","date":1623945600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"87.56","date":1623945600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.6资金面打败了16%的股票
主力控盘前10的股票
行业资金
医疗器械服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月18日 20:30
| 机构今日流向(万元) | 917.29 | 机构5日流向(万元) | -5021.26 |
| 机构10日流向(万元) | -6526.09 | 机构20日流向(万元) | -11520.74 |
机构持仓
2021-03-31 与 2020-12-31 相比，主力机构持仓量减少27.86万股，其中基金净减仓1家，主力净减仓21家，请投资者中长期谨慎为宜。
截止2021-03-31，共2家主力机构（基金2家），持仓量总计41.1万股，占流通A股1.37%
其中，基金持仓与2020-12-31相比：
增仓：0家 ，增持 0万股
减仓：1家 ，减持 3.44万股
新出现在主力名单中：1家 ，持有22.54万股
从主力名单中消失：22家 ，原持有46.96万股
其中，基金持仓与2020-12-31相比：
增仓：0家 ，增持 0万股
减仓：1家 ，减持 3.44万股
新出现在主力名单中：1家 ，持有22.54万股
从主力名单中消失：22家 ，原持有46.96万股
消息面诊股
诊断结果：7.5消息面打败了96%的股票
今日有利好新闻的公司
近期该股利好消息较多，投资者可加强关注。
更多>>个股资讯
- 医疗器械板块盘中异动拉升 新医改将推进高值医用耗材
2021-06-18 - 明德生物限售解禁特别提示(2021-06-18)
2021-06-18 - 明德生物：公司2021年第一季度海外业务收入未单独
2021-06-17 - 明德生物：2020年度公司软件产品和技术服务收入约
2021-06-17 - 明德生物限售解禁特别提示(2021-06-17)
2021-06-17 - 明德生物：主力机构活跃度动向解读
2021-06-16 - 明德生物新冠病毒中和抗体检测试剂获欧盟CE认证
2021-06-16 - 明德生物限售解禁特别提示(2021-06-16)
2021-06-16 - 明德生物限售解禁特别提示(2021-06-15)
2021-06-15 - 明德生物限售解禁特别提示(2021-06-14)
2021-06-14
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2021-05-10 |
| 利好 | 分红转增 | 10转4股派20.00元(含税) | 2021-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2021-04-28 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2021-04-15 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2021-01-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-11-13 |
| 一般消息 | 分红转增 | 不分配不转增 | 2020-08-24 |
| 一般消息 | 高管变动 | 个人原因 | 2020-08-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-07-14 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 2条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：2.2行业面打败了5%的股票
医疗器械服务行业最新资金流向
近10日来该行业走势不明显，跑输大盘。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2021.06.18","price":"0.77","value":"1.60"},{"date":"2021.06.17","price":"1.23","value":"0.63"},{"date":"2021.06.16","price":"-2.57","value":"-1.73"},{"date":"2021.06.15","price":"-0.86","value":"-1.10"},{"date":"2021.06.11","price":"-0.62","value":"-1.54"},{"date":"2021.06.10","price":"1.19","value":"-0.18"},{"date":"2021.06.09","price":"0.01","value":"-0.07"},{"date":"2021.06.08","price":"-0.98","value":"-1.47"},{"date":"2021.06.07","price":"-0.06","value":"0.48"},{"date":"2021.06.04","price":"0.74","value":"0.57"},{"date":"2021.06.03","price":"-0.65","value":"-1.24"},{"date":"2021.06.02","price":"-1.18","value":"-3.13"},{"date":"2021.06.01","price":"0.26","value":"1.10"},{"date":"2021.05.31","price":"0.97","value":"3.97"},{"date":"2021.05.28","price":"-0.30","value":"-1.27"},{"date":"2021.05.27","price":"0.70","value":"1.39"},{"date":"2021.05.26","price":"-0.36","value":"0.02"},{"date":"2021.05.25","price":"2.34","value":"2.19"},{"date":"2021.05.24","price":"0.62","value":"-0.02"},{"date":"2021.05.21","price":"-0.81","value":"-0.82"},{"date":"2021.05.20","price":"0.35","value":"0.59"}]
深证成指,医疗器械服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 拱东医疗 | 67.85% | 16.06% | 6.7分 |
| 2 | ST运盛 | 42.53% | 13.51% | 5.7分 |
| 3 | 艾隆科技 | 41.91% | 11.37% | 5.9分 |
| 4 | 赛诺医疗 | 27.21% | -3.20% | 5.3分 |
| 5 | *ST华塑 | 23.43% | 11.74% | 6.1分 |
| 6 | 美迪西 | 20.28% | 8.78% | 6.6分 |
| 8 | 鱼跃医疗 | 16.89% | 7.37% | 6.7分 |
| 10 | 惠泰医疗 | 15.91% | 5.44% | 6.2分 |
| 12 | 国际医学 | 11.83% | 9.67% | 5.0分 |
| 14 | 通策医疗 | 11.44% | -0.41% | 6.2分 |
| 16 | 爱博医疗 | 10.75% | 2.86% | 5.9分 |
| 18 | 阳普医疗 | 10.25% | 5.72% | 6.0分 |
| 20 | 国发股份 | 8.75% | 0.45% | 5.4分 |
| 22 | 爱尔眼科 | 8.16% | -3.46% | 5.6分 |
| 24 | 诺禾致源 | 7.64% | -11.56% | 4.9分 |
| 26 | 盈康生命 | 6.49% | -10.80% | 4.4分 |
| 28 | 欧普康视 | 6.05% | -5.02% | 5.2分 |
| 30 | 药明康德 | 5.50% | -6.54% | 5.4分 |
| 32 | 昊海生科 | 4.38% | 1.19% | 5.5分 |
| 34 | 迪瑞医疗 | 3.75% | -3.49% | 5.6分 |
| 36 | 济民医疗 | 2.49% | -2.07% | 3.5分 |
| 38 | 达安基因 | 2.10% | -4.90% | 5.3分 |
| 40 | 之江生物 | 1.86% | -0.31% | 4.7分 |
| 42 | 天智航 | 1.66% | -6.13% | 3.4分 |
| 44 | 博晖创新 | 1.02% | 0.13% | 4.8分 |
| 46 | 安必平 | 0.62% | -3.16% | 4.5分 |
| 48 | 宝莱特 | 0.22% | -3.79% | 4.2分 |
| 50 | 正海生物 | -0.06% | 6.12% | 6.4分 |
| 52 | 圣湘生物 | -0.57% | -2.64% | 5.0分 |
| 54 | 透景生命 | -1.20% | -2.36% | 5.2分 |
| 56 | 金域医学 | -1.66% | -0.13% | 6.3分 |
| 58 | 康德莱 | -1.89% | -15.88% | 4.2分 |
| 60 | 睿智医药 | -2.00% | -4.48% | 4.8分 |
| 62 | 乐凯胶片 | -2.07% | -4.94% | 5.0分 |
| 64 | 基蛋生物 | -2.65% | -2.55% | 5.4分 |
| 66 | 浩欧博 | -2.94% | -6.03% | 5.3分 |
| 68 | 开立医疗 | -3.09% | 0.91% | 5.1分 |
| 70 | 乐普医疗 | -3.26% | 0.91% | 5.1分 |
| 72 | *ST海医 | -3.81% | -4.04% | 4.9分 |
| 74 | 海泰新光 | -4.18% | 0.70% | 5.7分 |
| 76 | 天臣医疗 | -4.43% | -1.21% | 4.0分 |
| 78 | 赛科希德 | -4.77% | -1.30% | 4.6分 |
| 80 | 奥泰生物 | -4.97% | -2.60% | 4.7分 |
| 82 | 康众医疗 | -5.38% | -0.16% | 4.3分 |
| 84 | 大博医疗 | -5.56% | -1.70% | 5.3分 |
| 86 | 科华生物 | -5.98% | -1.71% | 4.8分 |
| 88 | 贝瑞基因 | -6.20% | -4.08% | 4.4分 |
| 90 | 南卫股份 | -6.83% | -5.03% | 4.2分 |
| 92 | 振德医疗 | -7.64% | -5.83% | 4.9分 |
| 94 | 蓝帆医疗 | -8.14% | 0.82% | 5.5分 |
| 96 | *ST恒康 | -8.54% | -5.14% | 4.9分 |
| 98 | 辰欣药业 | -8.67% | -3.22% | 4.8分 |
| 100 | 海尔生物 | -9.28% | -3.53% | 5.4分 |
| 102 | 三诺生物 | -9.50% | -2.30% | 5.2分 |
| 104 | 科美诊断 | -9.59% | 0.59% | 4.7分 |
| 106 | 迈克生物 | -10.36% | -3.13% | 5.1分 |
| 108 | 楚天科技 | -13.12% | -1.37% | 5.1分 |
| 110 | 山东药玻 | -14.35% | -8.12% | 4.0分 |
| 112 | 正川股份 | -16.34% | -2.85% | 4.9分 |
| 114 | 中红医疗 | -16.49% | -9.93% | 4.9分 |
| 116 | 澳洋健康 | -17.13% | -7.57% | 4.4分 |
| 118 | 美年健康 | -20.92% | -18.39% | 4.3分 |
| 120 | 睿昂基因 | -25.26% | -8.74% | 4.1分 |
| 122 | 亚辉龙 | -31.71% | -12.32% | 4.8分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2021-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/257 ， 18/257。
[{"date":"2021-03-31","value":"26.68","vol":"4.68"},{"date":"2020-12-31","value":"54.80","vol":"19.68"},{"date":"2020-09-30","value":"45.41","vol":"16.28"},{"date":"2020-06-30","value":"28.33","vol":"11.22"},{"date":"2020-03-31","value":"0.32","vol":"1.89"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
26.68 | 54.80 | 45.41 | 28.33 | 0.32 |
| 行业(%) | 4.68 | 19.68 | 16.28 | 11.22 | 1.89 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"76.66","vol":"53.38"},{"date":"2020-12-31","value":"78.21","vol":"53.05"},{"date":"2020-09-30","value":"81.44","vol":"48.99"},{"date":"2020-06-30","value":"83.75","vol":"51.66"},{"date":"2020-03-31","value":"70.84","vol":"46.04"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
76.66 | 78.21 | 81.44 | 83.75 | 70.84 |
| 行业(%) | 53.38 | 53.05 | 48.99 | 51.66 | 46.04 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/257 ， 2/257。
[{"date":"2021-03-31","value":"2270.97","vol":"156.47"},{"date":"2020-12-31","value":"429.43","vol":"68.23"},{"date":"2020-09-30","value":"358.07","vol":"61.45"},{"date":"2020-06-30","value":"253.98","vol":"49.26"},{"date":"2020-03-31","value":"-39.36","vol":"4.25"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
2270.97 | 429.43 | 358.07 | 253.98 | -39.36 |
| 行业(%) | 156.47 | 68.23 | 61.45 | 49.26 | 4.25 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"17448.99","vol":"1539.52"},{"date":"2020-12-31","value":"1029.24","vol":"223.61"},{"date":"2020-09-30","value":"695.53","vol":"179.47"},{"date":"2020-06-30","value":"397.19","vol":"141.11"},{"date":"2020-03-31","value":"-87.92","vol":"266.95"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
17448.99 | 1029.24 | 695.53 | 397.19 | -87.92 |
| 行业(%) | 1539.52 | 223.61 | 179.47 | 141.11 | 266.95 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 5/257 ， 45/257。
[{"date":"2021-03-31","value":"0.41","vol":"0.14"},{"date":"2020-12-31","value":"0.93","vol":"0.61"},{"date":"2020-09-30","value":"0.68","vol":"0.44"},{"date":"2020-06-30","value":"0.43","vol":"0.30"},{"date":"2020-03-31","value":"0.04","vol":"0.09"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.41 | 0.93 | 0.68 | 0.43 | 0.04 |
| 行业(次) | 0.14 | 0.61 | 0.44 | 0.30 | 0.09 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"0.96","vol":"22.23"},{"date":"2020-12-31","value":"2.66","vol":"67.90"},{"date":"2020-09-30","value":"1.48","vol":"44.44"},{"date":"2020-06-30","value":"1.00","vol":"25.49"},{"date":"2020-03-31","value":"0.20","vol":"10.93"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.96 | 2.66 | 1.48 | 1.00 | 0.20 |
| 行业(次) | 22.23 | 67.90 | 44.44 | 25.49 | 10.93 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2021-03-31","value":"37.38","vol":"1.21"},{"date":"2020-12-31","value":"47.39","vol":"28.38"},{"date":"2020-09-30","value":"16.54","vol":"20.42"},{"date":"2020-06-30","value":"45.78","vol":"23.20"},{"date":"2020-03-31","value":"36.08","vol":"-9.83"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 37.38 | 47.39 | 16.54 | 45.78 | 36.08 |
| 行业 | 1.21 | 28.38 | 20.42 | 23.20 | -9.83 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"","vol":"0.01"},{"date":"2020-12-31","value":"1.56","vol":"3.09"},{"date":"2020-09-30","value":"","vol":"0.11"},{"date":"2020-06-30","value":"1.53","vol":"2.27"},{"date":"2020-03-31","value":"","vol":"0.08"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.56 | - | 1.53 | - |
| 行业 | 0.01 | 3.09 | 0.11 | 2.27 | 0.08 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 75/257 ， 79/257。
[{"date":"2021-03-31","value":"4.24","vol":"5.48"},{"date":"2020-12-31","value":"3.94","vol":"4.76"},{"date":"2020-09-30","value":"3.79","vol":"5.36"},{"date":"2020-06-30","value":"3.70","vol":"3.82"},{"date":"2020-03-31","value":"4.56","vol":"3.66"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.24 | 3.94 | 3.79 | 3.70 | 4.56 |
| 行业 | 5.48 | 4.76 | 5.36 | 3.82 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"3.50","vol":"4.61"},{"date":"2020-12-31","value":"3.42","vol":"4.08"},{"date":"2020-09-30","value":"3.25","vol":"4.41"},{"date":"2020-06-30","value":"3.22","vol":"3.07"},{"date":"2020-03-31","value":"3.97","vol":"2.99"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.50 | 3.42 | 3.25 | 3.22 | 3.97 |
| 行业 | 4.61 | 4.08 | 4.41 | 3.07 | 2.99 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 67/257 ， 69/257。
[{"date":"2021-03-31","value":"20.93","vol":"26.81"},{"date":"2020-12-31","value":"21.85","vol":"28.47"},{"date":"2020-09-30","value":"22.36","vol":"28.55"},{"date":"2020-06-30","value":"22.25","vol":"31.04"},{"date":"2020-03-31","value":"17.45","vol":"27.15"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
20.93 | 21.85 | 22.36 | 22.25 | 17.45 |
| 行业(%) | 26.81 | 28.47 | 28.55 | 31.04 | 27.15 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"0.27","vol":"1.42"},{"date":"2020-12-31","value":"0.28","vol":"1.08"},{"date":"2020-09-30","value":"0.29","vol":"0.82"},{"date":"2020-06-30","value":"0.29","vol":"0.84"},{"date":"2020-03-31","value":"0.21","vol":"0.75"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.27 | 0.28 | 0.29 | 0.29 | 0.21 |
| 行业(%) | 1.42 | 1.08 | 0.82 | 0.84 | 0.75 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2021年的收益，请投资者后续关注。
[{"date":"2017","yellowRectValue":"0.65","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"0.61","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"0.42","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"4.69","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]